Avalere Health has hired Corrina Safeio as its new president of global marketing and executive vice president of corporate communications.
Safeio, a 25-year veteran of working both for agencies and on the client side, comes to Avalere from rival firm Inizio Evoke, where she was president of the European division, having also before this served stints at Mind+Matter and Pegasus.
In her new role, she will oversee Avalere’s global marketing team to “build meaningful connections and create customised strategic solutions for our clients, ultimately driving growth and leading to new opportunities for the organisation,” the agency said in a press release.
This comes about a year after the rebranding of what had been Fishawack Health into what is now Avalere Health. The agency in one form or another has been around since 2001 but was reborn last October.
That rebranding happened about 18 months after it snapped up Washington, D.C.-based healthcare consulting firm Avalere Health into its business.
That merger was also followed by a management shake-up four months later. During this restructuring, Ryan Mason was promoted to the new position of chief marketing and creative officer for the agency, and industry veteran Jeffrey Erb was brought on board as chief media officer.
“We're delighted to welcome Corrina to our team," said Mario Muredda, president of marketing at Avalere Health, in the release.
“She is an influential leader with a proven track record of delivering impactful marketing and PR solutions through evidence-based insights and award-winning creative. I'm excited to work with her to uncover new possibilities for our clients and the patients they serve." Safeio will report to Muredda.
Her new role will see her work on new suite of tools “designed to make sense of complex landscapes while engaging audiences across the product lifecycle,” while also developing a “new corporate communications framework designed to foster collaboration, connect capabilities, and activate 1,500+ team members across the world,” according to a statement.
“I'm inspired by the authenticity and ambition of the Avalere Health team," said Safeio. “It's an exciting time and I truly believe we have a unique opportunity to create new approaches and empower our teams to innovate without boundaries. We have the capability to help our clients succeed in the marketplace—from molecule to launch—and beyond. And what is distinct is the pace and agility that Avalere Health can move to create effective solutions.”